BackLexaria Bioscience - Warrants (11/01/2026) Overview

Lexaria Bioscience - Warrants (11/01/2026) Net Tangible Assets

Lexaria Bioscience - Warrants (11/01/2026)'s net tangible assets is $4.3M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$4.34M

Peer trimmed avg / median

Loading

Lexaria Bioscience - Warrants (11/01/2026) Net Tangible Assets History

Loading

Lexaria Bioscience - Warrants (11/01/2026) vs. peers: Net Tangible Assets Comparison

Loading

Lexaria Bioscience - Warrants (11/01/2026) Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Lexaria Bioscience - Warrants (11/01/2026) (LEXXW) FAQ

Lexaria Bioscience - Warrants (11/01/2026) (LEXXW) currently reports a net tangible assets of $4.3M as of May 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Lexaria Bioscience - Warrants (11/01/2026)'s net tangible assets history and peer comparisons.

Lexaria Bioscience - Warrants (11/01/2026)'s net tangible assets changed from $0 to $4.3M (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lexaria Bioscience - Warrants (11/01/2026) reported $4.3M in net tangible assets as of May 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $4.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lexaria Bioscience - Warrants (11/01/2026), and consider following LEXXW for alerts when major investors trade the stock.

Lexaria Bioscience - Warrants (11/01/2026) is classified in the Healthcare sector. On net tangible assets, it currently shows $4.3M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LEXXW with unrelated industries.